NEMLUVIO
@nemluvio.com
Official patient site for NEMLUVIO® (nemolizumab-ilto) for the treatment of prurigo nodularis (PN) and eczema (atopic dermatitis).
NEMLUVIO's Company Logos
NEMLUVIO's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#3B1A53
Grape
59, 26, 83
275, 52, 21
29, 69, 0, 67
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#0F0F10
Woodsmoke
15, 15, 16
240, 3, 6
6, 6, 0, 94
About NEMLUVIO
NEMLUVIO® (nemolizumab-ilto) is an innovative prescription medication developed by Galderma Laboratories, specifically for the treatment of moderate-to-severe eczema (atopic dermatitis) and prurigo nodularis in adults and children aged 12 years and older. Designed to provide rapid itch relief, NEMLUVIO works in conjunction with topical therapies when they fail to adequately control eczema symptoms. Clinical studies demonstrate that patients can experience significant itch relief in just 48 hours, promoting long-lasting skin healing.
NEMLUVIO's favorable safety profile and once-monthly dosing make it a convenient choice for those suffering from chronic skin conditions. While effective for adults, its safety and efficacy in younger patients remain undetermined, emphasizing the importance of consulting healthcare professionals. Galderma also offers dedicated support through Galderma Patient Services (GPS) to assist patients in navigating their treatment experience with NEMLUVIO, ensuring comprehensive care tailored to each individual's needs.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
Related Brands
Tags
Biologic injection medicine
Atopic dermatitis treatment
Prurigo nodularis treatment
Patient access and affordability program
